Cvs Health Corp Stock Buy Hold or Sell Recommendation
| CVS Stock | USD 56.83 1.06 1.90% |
Considering the 90-day investment horizon and your typical level of risk aversion, our recommendation regarding CVS Health Corp is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell CVS Health Corp given historical horizon and risk tolerance towards CVS Health. When Macroaxis issues a 'buy' or 'sell' recommendation for CVS Health Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out CVS Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as CVS and provide practical buy, sell, or hold advice based on investors' constraints. CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
CVS |
Execute CVS Health Buy or Sell Advice
The CVS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CVS Health Corp. Macroaxis does not own or have any residual interests in CVS Health Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CVS Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
CVS Health Trading Alerts and Improvement Suggestions
| CVS Health Corp generated a negative expected return over the last 90 days | |
| CVS Health Corp has 79.39 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for CVS to invest in growth at high rates of return. | |
| Over 83.0% of CVS Health shares are held by institutions such as insurance companies | |
| On 1st of November 2024 CVS Health paid $ 0.665 per share dividend to its current shareholders | |
| Latest headline from benzinga.com: Big Pharmas Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System |
CVS Health Returns Distribution Density
The distribution of CVS Health's historical returns is an attempt to chart the uncertainty of CVS Health's future price movements. The chart of the probability distribution of CVS Health daily returns describes the distribution of returns around its average expected value. We use CVS Health Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CVS Health returns is essential to provide solid investment advice for CVS Health.
| Mean Return | -0.0069 | Value At Risk | -3.45 | Potential Upside | 3.35 | Standard Deviation | 2.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CVS Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CVS Stock Institutional Investors
The CVS Health's institutional investors refer to entities that pool money to purchase CVS Health's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 13.9 M | Franklin Resources Inc | 2024-06-30 | 13.8 M | Pzena Investment Management, Llc | 2024-09-30 | 13.1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 12.2 M | Amvescap Plc. | 2024-06-30 | 12.1 M | Glenview Capital Management Llc | 2024-09-30 | 11.9 M | Northern Trust Corp | 2024-09-30 | 11.6 M | Legal & General Group Plc | 2024-06-30 | 11.4 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 10.2 M | Vanguard Group Inc | 2024-09-30 | 117.6 M | Blackrock Inc | 2024-06-30 | 100.2 M |
CVS Health Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.1B) | (973M) | 735M | (1.4B) | 1.2B | 1.3B | |
| Change In Cash | 1.7B | 2.2B | 1.6B | 614M | (4.8B) | (4.5B) | |
| Free Cash Flow | 10.4B | 13.4B | 15.7B | 13.5B | 10.4B | 10.9B | |
| Depreciation | 4.4B | 4.4B | 4.5B | 4.2B | 4.4B | 4.6B | |
| Other Non Cash Items | 548M | 1.2B | 1.9B | 2.4B | 765M | 606.8M | |
| Dividends Paid | 2.6B | 2.6B | 2.6B | 2.9B | 3.1B | 3.3B | |
| Capital Expenditures | 2.5B | 2.4B | 2.5B | 2.7B | 3.0B | 1.6B | |
| Net Income | 6.6B | 7.2B | 7.9B | 4.2B | 8.4B | 8.8B | |
| End Period Cash Flow | 6.0B | 8.1B | 12.7B | 13.3B | 8.5B | 9.0B | |
| Investments | (485M) | (3.2B) | (2.7B) | (1.0B) | (19.8B) | (18.8B) | |
| Change Receivables | 2.2B | (1.5B) | (2.7B) | 3.0B | 3.4B | 3.6B | |
| Net Borrowings | (5.3B) | (5.7B) | (9.3B) | (4.2B) | (3.8B) | (3.6B) | |
| Change To Netincome | 453M | 1.1B | 549M | 2.5B | 2.9B | 3.1B |
CVS Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CVS Health or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CVS Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CVS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 1.55 | |
σ | Overall volatility | 2.53 | |
Ir | Information ratio | -0.04 |
CVS Health Volatility Alert
CVS Health Corp exhibits very low volatility with skewness of 1.02 and kurtosis of 6.39. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CVS Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CVS Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.CVS Health Fundamentals Vs Peers
Comparing CVS Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CVS Health's direct or indirect competition across all of the common fundamentals between CVS Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as CVS Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CVS Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CVS Health to competition |
| Fundamentals | CVS Health | Peer Average |
| Return On Equity | 0.067 | -0.31 |
| Return On Asset | 0.0237 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 144.54 B | 16.62 B |
| Shares Outstanding | 1.26 B | 571.82 M |
| Shares Owned By Insiders | 0.11 % | 10.09 % |
| Shares Owned By Institutions | 82.75 % | 39.21 % |
| Number Of Shares Shorted | 21.85 M | 4.71 M |
| Price To Earning | 42.99 X | 28.72 X |
| Price To Book | 0.95 X | 9.51 X |
| Price To Sales | 0.19 X | 11.42 X |
| Revenue | 357.78 B | 9.43 B |
| Gross Profit | 53.46 B | 27.38 B |
| EBITDA | 13.74 B | 3.9 B |
| Net Income | 8.37 B | 570.98 M |
| Cash And Equivalents | 12.95 B | 2.7 B |
| Cash Per Share | 15.21 X | 5.01 X |
| Total Debt | 79.39 B | 5.32 B |
| Debt To Equity | 1.00 % | 48.70 % |
| Current Ratio | 0.94 X | 2.16 X |
| Book Value Per Share | 59.57 X | 1.93 K |
| Cash Flow From Operations | 13.43 B | 971.22 M |
| Short Ratio | 1.65 X | 4.00 X |
| Earnings Per Share | 3.94 X | 3.12 X |
| Price To Earnings To Growth | 1.96 X | 4.89 X |
| Target Price | 68.38 | |
| Number Of Employees | 219 K | 18.84 K |
| Beta | 0.54 | -0.15 |
| Market Capitalization | 71.52 B | 19.03 B |
| Total Asset | 249.73 B | 29.47 B |
| Retained Earnings | 61.6 B | 9.33 B |
| Working Capital | (11.33 B) | 1.48 B |
Note: Acquisition by Roger Farah of 4411 shares of CVS Health subject to Rule 16b-3 [view details]
CVS Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CVS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About CVS Health Buy or Sell Advice
When is the right time to buy or sell CVS Health Corp? Buying financial instruments such as CVS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CVS Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.